News
5h
Zacks Investment Research on MSNWhy This 1 Growth Stock Could Be a Great Addition to Your PortfolioIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
We expect Amgen AMGN to beat expectations when it reports second-quarter 2025 results on Aug. 5 after market close. In the last reported quarter, the company beat earnings expectations by 17.8%. The ...
Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2d
Zacks Investment Research on MSNAre You a Value Investor? This 1 Stock Could Be the Perfect PickTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
As August 5 approaches, Amgen (AMGN) gears up to reveal its Q2 2025 earnings after market close, and expectations are high ...
William Blair also maintained an Outperform rating, highlighting the potential revenue growth from Amgen’s broader portfolio, including drugs like Repatha and Imdelltra. 3rd party Ad.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become ...
The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.
Recent positive developments strengthen the bull case: IMDELLTRA showing superior survival results in lung cancer trials, FDA approval of UPLIZNA as the first treatment for IgG4-RD, and Q1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results